Prime Medicine, Inc. Quarterly Depreciation, Depletion and Amortization in USD from Q3 2021 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Prime Medicine, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q3 2021 to Q3 2024.
- Prime Medicine, Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $1.56M, a 26.1% increase year-over-year.
- Prime Medicine, Inc. Depreciation, Depletion and Amortization for the twelve months ending September 30, 2024 was $5.66M, a 32.3% increase year-over-year.
- Prime Medicine, Inc. annual Depreciation, Depletion and Amortization for 2023 was $4.65M, a 109% increase from 2022.
- Prime Medicine, Inc. annual Depreciation, Depletion and Amortization for 2022 was $2.22M, a 292% increase from 2021.
- Prime Medicine, Inc. annual Depreciation, Depletion and Amortization for 2021 was $568K, a 1221% increase from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)